Key result
A multidrug chemotherapy regimen resulted in clinically significant tumor regression in 7 of 9 children (77.8%) with osteogenic sarcoma.
Why the study?
Does a multidrug chemotherapy regimen improve tumor regression in children with osteogenic sarcoma?
Population
9 children with clinically evaluable osteogenic sarcoma and no previous chemotherapeutic treatment
Design
Case_series
Follow-up
5 to 20+ months
Authors
Loading...
Does not support practice change in pediatric osteosarcoma; hypothesis-generating and requires prospective trials.
Does a multidrug chemotherapy regimen improve tumor regression in children with osteogenic sarcoma?
A multidrug chemotherapy regimen showed clinically significant tumor regression in 7 out of 9 children with osteogenic sarcoma.
Rosen et al. (1975) studied Osteogenic sarcoma (n=9). Multidrug chemotherapy regimen was evaluated on Clinically significant responses with tumor regression. A multidrug chemotherapy regimen resulted in clinically significant tumor regression in 7 of 9 children (77.8%) with osteogenic sarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: